Actions of the phosphodiesterase inhibitor zardaverine on guinea-pig ventricular muscle
- 1 August 1990
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 342 (2) , 221-227
- https://doi.org/10.1007/bf00166968
Abstract
The positive inotropic action of the phosphodiesterase inhibitor zardaverine was investigated in guinea-pig heart muscle. In right papillary muscles, 1–30 μM zardaverine reversibly increased the force of contraction in a concentration-dependent manner. This effect was accompanied by a shortening of contraction and relaxation times. Resting membrane potential was unchanged, whereas action potential amplitude was significantly increased and duration was reduced. In papillary muscles partially depolarised with 22 mM K+, zardaverine (10 and 30 μLM) restored slow action potentials, which were not influenced by cimetidine, propranolol or prazosin but were blocked by the calcium channel blocker (+)-nitrendipine or the muscarinic agonist carbachol. cAMP-specific phosphodiesterase III, isolated from guinea-pig ventricular muscle was inhibited by zardaverine as was cAMP-specific phosphodiesterase IV, isolated from dog trachea (IC50s: 0.5 and 0.8 μM, respectively). The results suggest that the observed positive inotropic and electrophysiological effects result from an inhibition of cellular phosphodiesterase.This publication has 32 references indexed in Scilit:
- Beta-adrenergic modulation of cardiac ion channels. Differential temperature sensitivity of potassium and calcium currents.The Journal of general physiology, 1989
- Pharmacological Actions of DPN 205–734, a Novel Cardiotonic AgentJournal of Cardiovascular Pharmacology, 1988
- Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility.Circulation Research, 1987
- Is Phosphodiesterase Inhibition Arrhythmogenic? Electrophysiologic Effects in Pithed Rats and in Normoxic and Hypoxic Rabbit Atria of Enoximone, a New Cardiotonic AgentThe Journal of Clinical Pharmacology, 1987
- The Role of Novel Inotropic Agents in the Treatment of Heart FailureJournal of Cardiovascular Pharmacology, 1986
- Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockadeNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1986
- Studies on the Mechanism of the Positive Inotropic Effect of Piroximone in Cat Papillary MuscleJournal of Cardiovascular Pharmacology, 1985
- Positive Inotropic and Electrophysiological Effects of APP 201-533 Can Be Explained by an Increase of Cardiac Cyclic AMPJournal of Cardiovascular Pharmacology, 1985
- Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failureJournal of Medicinal Chemistry, 1984
- Biphasic Action of Acetylcholine on Ventricular MyocardiumCirculation Research, 1965